New Phase

New Phase is a medical technology company dedicated to advancing cancer care, particularly for patients with stage IV cancer. The company has developed the Sarah Nanotechnology System, a unique medical device that utilizes electromagnetic hyperthermia to target metastatic solid tumors. This system delivers controlled heat to cancer cells, effectively causing their death while protecting healthy cells. Recognized by the FDA, the Sarah Nanotechnology System benefits from a streamlined regulatory pathway, allowing for quicker market entry and reduced clinical costs compared to traditional pharmaceutical treatments. New Phase has a robust intellectual property portfolio with 13 granted patents worldwide, covering innovative technologies related to nanoparticle temperature control. The company has successfully treated over 20 patients in early feasibility studies, demonstrating promising safety results. Headquartered in Petah Tikva, Israel, New Phase emphasizes collaboration with leading oncology hospitals and scientific experts. The company is committed to innovation and improving patient outcomes, aiming to redefine cancer treatment paradigms and enhance the quality of life for patients.

• Employees 25
• Founded 2013